Navigation Links
Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009
Date:7/14/2009

expansion stage of the trial, which will enroll a total of 46 advanced breast cancer patients overall.
  • Reported that in a Phase II trial evaluating bavituximab in combination with carboplatin and paclitaxel in non-small cell lung cancer (NSCLC) patients with locally advanced or metastatic disease, 11 of 17, or almost 65% of evaluable patients in the initial cohort, achieved an objective tumor response according to RECIST criteria. These early results, which exceeded the pre-specified endpoint needed to expand the trial, compare very favorably with historical data with chemotherapy alone and are especially encouraging in this hard-to-treat cancer. Patient enrollment and dosing are continuing in the expansion stage of the trial, which will enroll a total of 49 NSCLC patients overall.
  • Completed patient enrollment in a Phase I trial evaluating bavituximab as monotherapy in patients with advanced refractory cancers. At the 2009 ASCO Annual Meeting, study researchers reported that bavituximab had demonstrated a predictable pharmacokinetic profile and acceptable safety, and that a maximum tolerated dose was not reached, even at the highest planned dose level.
  • Announced that the ASCO Research Foundation awarded one of its 2009 Career Development Awards to a researcher at the University of Texas Southwestern Medical Center for a study of the biologic effects of bavituximab and chemotherapy in patients with advanced lung cancer.
  • Presented data from two studies at the AACR 2009 Annual Meeting providing further confirmation of the unique immunomodulatory mechanisms contributing to the anti-tumor activity of Peregrine's anti-PS antibody platform.
  • Bavituximab Anti-Viral Program

    The company continued to advance the bavituximab anti-viral program:

    • Received major validation of the broad anti-viral potential of the company's anti-PS antib
      '/>"/>

    SOURCE Peregrine Pharmaceuticals, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

    Related medicine news :

    1. Positive Results From Peregrine Pharmaceuticals Bavituximab Phase l HCV Trial Presented at AASLD Meeting
    2. Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
    3. Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials
    4. Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals Bavituximab to Cure Lethal Virus Infections
    5. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
    6. Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2009
    7. Peregrine Pharmaceuticals Bavituximab Achieves Primary Endpoint in First Stage of Phase II Breast Cancer Study
    8. Peregrine Pharmaceuticals to Report Third Quarter FY 2009 Financial Results
    9. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
    10. Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program
    11. ASCO Research Foundation Grant Will Support Study of Peregrines Bavituximab in Lung Cancer
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/22/2014)... HealthDay Reporter MONDAY, Sept. 22, ... brain processes sounds might help identify the severity of ... children,s brainwaves may also allow identification of autism earlier ... "The finding that the brain,s response to certain types ... promising," said senior researcher Sophie Molholm, an associate professor ...
    (Date:9/22/2014)... 22, 2014 Medical experts this ... three-day conference to discuss brain-related diseases facing an ... concussions and neurodegenerative disorders. , Each of ... with a Silverado memory care community or hospice ... in memory care, hosts the annual event to ...
    (Date:9/22/2014)... The report segments the global physiotherapy ... geography. The equipment segment accounted for a lion’s ... product. However, the accessories segment is expected to ... period, owing to the rising demand of physiotherapy ... segments are the fastest-growing segments in the physiotherapy ...
    (Date:9/22/2014)... participate in athletics will be asked to sign a ... ensure parents are confident about handling the injury, according ... Hospital National Poll on Children,s Health. , In the ... and high school children surveyed reported participation in some ... read a brochure or online information, 17% have ...
    (Date:9/22/2014)... Senators Sherrod Brown (D-Ohio) and Patty Murray (D-Wash.) ... were lauded yesterday by the American College of ... medicine and related subspecialties. A letter sent ... Ensuring Access to Primary Care for Women & ... payment rates under Medicaid for certain primary care ...
    Breaking Medicine News(10 mins):Health News:Brainwaves May Help Gauge Autism Severity: Study 2Health News:Brainwaves May Help Gauge Autism Severity: Study 3Health News:Brainwaves May Help Gauge Autism Severity: Study 4Health News:Nation’s Leading Brain Health Experts Gather for Annual Silverado Medical Director Conference 2Health News:Nation’s Leading Brain Health Experts Gather for Annual Silverado Medical Director Conference 3Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 2Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 3Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 4Health News:6.8% CAGR for Physiotherapy Equipment Market Globally to 2019 Says a New Research Report Available at ReportsnReports.com 5Health News:Some concussion education more useful than others, parents say 2Health News:Broad physician coalition urges Congress to extend Medicaid pay parity 2
    ... Rehab Market , , PHILADELPHIA, ... 35 years of experience, has joined Alliance Seating & ... rehab companies. O,Neill is an Assistive Technology Supplier ... is responsible for sales and service of rehabilitation equipment and ...
    ... will hold its annual Mid-Winter Educational Symposium February 5-8, ... year SNM, the American College of Nuclear Physicians (ACNP) ... to create a fused meeting, offering attendees the opportunity ... strength and range of the education content that will ...
    ... Dec. 16 Parents of children with autism are,struggling ... of their lives, and,are particularly fearful that their family ... challenges of autism, according to a new,study released today ... , Easter Seals, Living with Autism Study ...
    ... Also Shows Nearly 145,000 TotalHospital Jobs , , ... a key economic engine for the state, providing more than 113,000 ... billion in total spending, according to the New Jersey Hospitals ... Hospitals have long been known for their societal contributions, including ...
    ... 16 WellPoint, Inc. (NYSE: WLP ), ... plans to collaboratively partner with four Blue Cross and/or ... online, consumer-friendly,health care cost information. , ... in this initiative are,Highmark Inc. (Pennsylvania), Premera Blue Cross ...
    ... Center for Career and Technical Education, funded by the Office ... Education, has outlined an aggressive research agenda focused on areas ... education (CTE), and using data to assess student performance. , ... Research Center will be on three major components of effective ...
    Cached Medicine News:Health News:Veteran Rehab Specialist, Ted O'Neill, Joins Fast-Growing Alliance Seating & Mobility in Pennsylvania 2Health News:SNM's Mid-Winter Educational Symposium for nuclear medicine and molecular imaging professionals 2Health News:Easter Seals' Study Sheds New Light on Parents' Life-Long Fears, Anxieties and Critical Supports Needed to Raise a Child With Autism 2Health News:Easter Seals' Study Sheds New Light on Parents' Life-Long Fears, Anxieties and Critical Supports Needed to Raise a Child With Autism 3Health News:Easter Seals' Study Sheds New Light on Parents' Life-Long Fears, Anxieties and Critical Supports Needed to Raise a Child With Autism 4Health News:Easter Seals' Study Sheds New Light on Parents' Life-Long Fears, Anxieties and Critical Supports Needed to Raise a Child With Autism 5Health News:Easter Seals' Study Sheds New Light on Parents' Life-Long Fears, Anxieties and Critical Supports Needed to Raise a Child With Autism 6Health News:Report: Hospitals Pump $18 Billion Into N.J. Economy 2Health News:WellPoint Announces Collaborative Partnership to Expand Access to Health Care Provider Information 2Health News:WellPoint Announces Collaborative Partnership to Expand Access to Health Care Provider Information 3Health News:WellPoint Announces Collaborative Partnership to Expand Access to Health Care Provider Information 4Health News:National CTE Research Center Outlines Projects 2Health News:National CTE Research Center Outlines Projects 3
    (Date:9/22/2014)... 22, 2014 Research and Markets ... "Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, ... to their offering. On the ... technologies market has been divided into eight major ... hydrothermal, and hydromechanical ablation technologies. The light/laser ablation ...
    (Date:9/22/2014)... MEDICAL CORP. (NYSE: CMN ) will release  the ... 31, 2014 on Monday, September 29 before the market opens, ... 11:00 AM ET. Participating in the call will be ... President and CEO; Jorgen B. Hansen , Executive Vice ... President, CFO and Treasurer; and Seth Yellin , Senior ...
    (Date:9/22/2014)... , Sept. 22, 2014  AbbVie (NYSE: ... clinical studies evaluating potential new medicines in the ... upcoming 2014 European Society of Medical Oncology (ESMO) ... Spain . Data being presented include results ... and efficacy of veliparib (ABT-888), a poly (adenosine ...
    Breaking Medicine Technology:Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 2Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 3Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Fourth Quarter And Fiscal 2014 Ended July 31, 2014 2AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 2AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 3AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 4
    Suitable for children and adults. New mechanical design of the skull pin holder and the clamp base ensures improved rigid skull fixation....
    It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
    ... is designed for rigid skeletal ... greater freedom in positioning the ... skeletal fixation is designed for ... sitting positions. Craniotomies can be ...
    ... endoscopes for general applications and are equipped with ... borescopes, i.e. rigid endoscopes, range between 1 mm ... up to a 120 retrospection, and image angles ... view. Endoscopes with working lengths of 1.5 meters ...
    Medicine Products: